TY - JOUR
T1 - The contribution of GMP-grade hospital preparation to translational research
AU - Yonezawa, Atsushi
AU - Kajiwara, Moto
AU - Minami, Ikuko
AU - Omura, Tomohiro
AU - Nakagawa, Shunsaku
AU - Matsubara, Kazuo
N1 - Publisher Copyright:
© 2015 The Pharmaceutical Society of Japan.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Translational research is important for applying the outcomes of basic research studies to practical medical treatments. In exploratory early-phase clinical trials for an innovative therapy, researchers should generally manufacture investigational agents by themselves. To provide investigational agents with safety and high quality in clinical studies, appropriate production management and quality control are essential. In the Department of Pharmacy of Kyoto University Hospital, a manufacturing facility for sterile drugs was established, independent of existing manufacturing facilities. Manuals on production management and quality control were developed according to Good Manufacturing Practices (GMP) for Investigational New Drugs (INDs). Advanced clinical research has been carried out using investigational agents manufactured in our facility. These achievements contribute to both the safety of patients and the reliability of clinical studies. In addition, we are able to do licensing-out of our technique for the manufacture of investigational drugs. In this symposium, we will introduce our GMP grade manufacturing facility for sterile drugs and discuss the role of GMP grade hospital preparation in translational research.
AB - Translational research is important for applying the outcomes of basic research studies to practical medical treatments. In exploratory early-phase clinical trials for an innovative therapy, researchers should generally manufacture investigational agents by themselves. To provide investigational agents with safety and high quality in clinical studies, appropriate production management and quality control are essential. In the Department of Pharmacy of Kyoto University Hospital, a manufacturing facility for sterile drugs was established, independent of existing manufacturing facilities. Manuals on production management and quality control were developed according to Good Manufacturing Practices (GMP) for Investigational New Drugs (INDs). Advanced clinical research has been carried out using investigational agents manufactured in our facility. These achievements contribute to both the safety of patients and the reliability of clinical studies. In addition, we are able to do licensing-out of our technique for the manufacture of investigational drugs. In this symposium, we will introduce our GMP grade manufacturing facility for sterile drugs and discuss the role of GMP grade hospital preparation in translational research.
KW - Good manufacturing practice
KW - Hospital preparation
KW - Investigational new drug
KW - Translational research
UR - http://www.scopus.com/inward/record.url?scp=84938505432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938505432&partnerID=8YFLogxK
U2 - 10.1248/yakushi.15-00112-3
DO - 10.1248/yakushi.15-00112-3
M3 - Article
C2 - 26234351
AN - SCOPUS:84938505432
SN - 0031-6903
VL - 135
SP - 943
EP - 947
JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
IS - 8
ER -